| [1] |
Son MB, Newbuger JW.Kawasaki disease[J]．Pediatr Rev，2013，34(4)：151–162.
|
| [2] |
Nweburger JW，Takahashi M，Gerber MA，et al.Diagnosis，treatment and long-term management of Kawasaki disease：a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, american heart association[J]. Pediatrics，2004，114(6)：1708–1733.
|
| [3] |
胡亚美，江载芳．诸福棠实用儿科学.7版[M]．北京：人民卫生出版社，2002：698–705.
|
| [4] |
Gerding R. Kawasaki disease: a review[J]. J Pediatr Health Care, 2011，25(6)：379–387.
|
| [5] |
Harada K．Intravenous gamma-globulin treatment in Kawasaki disease[J]．Acta Paediatr Jpn，1991，33(6)：805–810.
|
| [6] |
Giannouli G，Tzoumaka-Bakoula C，Kopsidas I，et al.Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period[J]. Pediatr Cardiol，2013，34(6)：1476–1481.
|
| [7] |
孙毅平，贾雷，韩波，等．川崎病并发冠状动脉病变危险因素分析[J]．中国实用儿科杂志，2013，28(5)：386–388.
|
| [8] |
李焰，王献民，柳颐龄，等．川崎病患儿并发冠状动脉病变的危险因素分析[J]．中国当代儿科杂志，2012，14(12)：938–941.
|
| [9] |
闫小红，刘淑霞，刘云，等．川崎病流行病学特征及冠状动脉损害的相关因素分析[J]．临床儿科杂志，2010，28(7)：636–639.
|
| [10] |
Luca NJ, Yeung RS. Epidemiology and management of Kawasaki disease[J]. Drugs, 2012，72(8)：1029–1038.
|
| [11] |
姜慧，黄昱，曾川. 与川崎病有关的细胞因子基因多态性[J]．临床儿科杂志，2013，3(1)：85–88.
|
| [12] |
Harnder A, Takahashi M, Burgner D. Kawasaki disease[J]．BMJ，2009，338：b1514.
|
| [13] |
Yeom JS，Woo HO，Park JS，et al.Kawasaki disease in infants[J]．Korean J Pediatr，2013，56(9)：377–382.
|
| [14] |
Yeung RS. Kawasaki disease：update on pathogenesis[J]．Curr Opin Rheumatol, 2010，22(5)：551–560.
|
| [15] |
Galeotti C, Bavry J, Kone-Paut I, et al. Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin[J]．Autoimmun Rev, 2010，6(9)：442–446.
|
| [16] |
Kaneko K，Takahashi M，Yoshimura K, et al. Intravenous innumoglobulin counteracts oxidative stress in Kawasaki disease[J]．Pediatr Cardiol, 2012，33(7)：1086–1088.
|
| [17] |
Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin[J]. N Engl J Med, 1986，315(6)：341–347.
|
| [18] |
Durongpisitkul K, Gururaj VJ, Park JM，et al.The prevention of coronary artery aneurysm in Kawasaki disease：a meta-analysis on the efficacy of aspirin and immunoglobulin treatment[J]．Pediatrics，1995，96(6)：1057–1061.
|
| [19] |
Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children[J]．Jpn J Allergy，1967，16(3)：178–222.
|
| [20] |
Anderson MS，Burns J，Treadwell TA，et al. Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in kawasaki disease[J]．Pediatr Infect Dis J，2001，20(7)：698–702.
|
| [21] |
Song XY，Huang JY, Hong Q，et al.Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease：ROC analysis[J]．J Clin Lab Anal, 2010，24(6)：385–388.
|
| [22] |
薛清，徐志云，韩林，等．川崎病伴发冠状动脉损害的外科治疗[J/CD]．中华临床医师杂志：电子版，2011，5(21)：6236–6238.
|